Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...
ROME, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology company, announced today that they signed an ...
Silo Pharma, Inc., a biopharmaceutical company focused on developing innovative treatments for mental health and chronic pain, announced in a recent letter to shareholders that it expects to submit an ...
Sophie Lamle brings over 20 years of experience in the pharmaceutical industry, leading innovation, clinical development, and strategic transformation. Her appointment will further strengthen LEO ...
LGM Pharma’s Expanded Contract Development and Manufacturing Organization (CDMO) Capabilities Will Enable Customers to Accelerate and Optimize the New Product Pathway from Early Development Through ...
Partnerships in healthcare have never been more important. Through collaboration, industry specialists are increasingly bringing cutting-edge medical innovations and life-changing treatments to ...
Aurobindo's wholly owned subsidiary, Aurobindo Pharma USA, has entered into a collaboration and license agreement with an unnamed global pharma company for the development and commercialization of ...
-Companies to advance four promising Sunovion compounds for people living with serious neuropsychiatric conditions- MARLBOROUGH, Mass. & OSAKA, Japan & TOKYO, Japan--(BUSINESS WIRE)--Sunovion ...
Kal Patel, M.D., is CEO and cofounder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health. Digital transformation has taken hold in almost every ...
Donna Conroy, MS is Founder/CEO of SciMar ONE, Inc. a technology company building AI-based SaaS solutions for the pharmaceutical industry. Investing time and resources is clearly a long-term strategy ...
Sterling Pharma Solutions will spend $13 million to add process development labs and commercial-scale manufacturing equipment for pharmaceutical chemicals at its site in Dudley, England. The project ...
Agreement further expands Angelini Pharma’s strong portfolio and deep therapeutic expertise in brain health, following a series of strategic partnerships in the space, including in orphan and rare ...